Análisis de la cuota de mercado y oportunidades de los antihelmínticos para mascotas (2025-2031)
Pet Anthelmintic Drugs Market Report Analysis
Pet Anthelmintic Drugs Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Novartis AG
- Cipla Inc.
- Sun Pharmaceutical Industries Ltd
- Amneal Pharmaceuticals LLC. (Impax Laboratories, Inc.)
- Zoetis, Inc.
- GlaxoSmithKline plc
- Bayer AG
- Merck & Co., Inc. (Intervet Inc.)
- Boehringer Ingelheim International GmbH
Regional Overview
- América del Norte
- Europa
- Asia-Pacífico
- América del Sur y Central
- Medio Oriente y África
Market Segmentation
By Patógeno objetivo
- Ascaris lumbricoides [lombriz intestinal]
- Trichuris Trichiura [tricocéfalo]
- Enterobius vermicularis [oxiuros]
- Ancylostoma duodenale [uncinaria]
- otros
By Canal de Distribución
- Farmacias Veterinarias
- Hospitales y Clínicas Veterinarias
By Geografía
- América del Norte
- Europa
- Asia-Pacífico
- América del Sur y Central
Get Free Sample For